TransMedics Group, Inc. stock is up 88.55% since 30 days ago. The next earnings date is Feb 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 4 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 34% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
14 Nov 20:18 | 17 Nov, 2023 | 45.00 | 308 | ||
16 Nov 17:45 | 19 Jan, 2024 | 65.00 | 138 | ||
17 Nov 17:13 | 15 Dec, 2023 | 70.00 | 350 | ||
21 Nov 15:59 | 15 Dec, 2023 | 70.00 | 469 | ||
21 Nov 16:01 | 19 Apr, 2024 | 50.00 | 11 | ||
21 Nov 16:01 | 19 Apr, 2024 | 95.00 | 6 | ||
27 Nov 18:58 | 20 Dec, 2024 | 90.00 | 1 | ||
29 Nov 20:17 | 19 Jan, 2024 | 40.00 | 37 | ||
01 Dec 17:49 | 19 Jan, 2024 | 45.00 | 14 | ||
04 Dec 14:48 | 19 Jan, 2024 | 80.00 | 89 |
TransMedics Group, Inc. engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system. OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation.